SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001521536-12-001115
Filing Date
2012-11-14
Accepted
2012-11-14 15:29:07
Documents
9
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 q1100822_10q-biozone.htm 10-Q 484810
2 q1100822_ex31-1.htm EX-31.1 9352
3 q1100822_ex32-1.htm EX-32.1 5185
  Complete submission text file 0001521536-12-001115.txt   3699060

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE bzne-20120930.xml EX-101.INS 420151
5 XBRL SCHEMA FILE bzne-20120930.xsd EX-101.SCH 42885
6 XBRL CALCULATION FILE bzne-20120930_cal.xml EX-101.CAL 40428
7 XBRL DEFINITION FILE bzne-20120930_def.xml EX-101.DEF 157154
8 XBRL LABEL FILE bzne-20120930_lab.xml EX-101.LAB 229242
9 XBRL PRESENTATION FILE bzne-20120930_pre.xml EX-101.PRE 223756
Mailing Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137 800-689-0930
BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-146182 | Film No.: 121203987
SIC: 2834 Pharmaceutical Preparations